Home » Stocks » TherapeuticsMD

TherapeuticsMD, Inc. (TXMD)

Stock Price: $1.61 USD -0.44 (-21.46%)
Updated Aug 6, 2020 4:00 PM EDT - Market closed
After-hours: $1.68 +0.07 (4.35%) Aug 6, 7:58 PM

Stock Price Chart

Key Info

Market Cap 437.41M
Revenue (ttm) 57.95M
Net Income (ttm) -193.49M
Shares Out 271.68M
EPS (ttm) -0.76
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 6, 2020
Last Price $1.61
Previous Close $2.05
Change ($) -0.44
Change (%) -21.46%
Day's Open 1.79
Day's Range 1.58 - 1.85
Day's Volume 13,621,633
52-Week Range 0.85 - 4.32

More Stats

Market Cap 437.41M
Enterprise Value 519.52M
Earnings Date (est) Nov 4, 2020
Ex-Dividend Date n/a
Shares Outstanding 271.68M
Float 244.70M
EPS (basic) -0.76
EPS (diluted) -0.76
FCF / Share -0.62
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 82.86M
Short Ratio 17.31
Short % of Float 33.87%
Beta 2.15
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 7.55
PB Ratio 40.75
Revenue 57.95M
Operating Income -164.02M
Net Income -193.49M
Free Cash Flow -168.85M
Net Cash -82.11M
Net Cash / Share -0.30
Gross Margin 74.74%
Operating Margin -283.04%
Profit Margin -333.90%
FCF Margin -291.37%
ROA -45.51%
ROE -2,499.18%
ROIC -82.20%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (9)

Buy 7
Overweight 0
Hold 2
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

(344.72% upside)
Current: $1.61
Target: 7.16
*Average 12-month price target from 8 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth208.38%-4.04%-13.32%-3.9%34.05%71.23%129.85%82.84%68.14%-
Gross Profit43.3113.3614.1415.1715.6411.356.822.471.140.69
Operating Income-151-130-77.63-90.25-85.19-54.04-25.81-16.15-5.43-2.87
Net Income-176-133-76.93-89.88-85.08-54.22-28.42-35.12-12.91-2.87
Shares Outstanding24622520619617315012891.6362.5238.29
Earnings Per Share-0.72-0.59-0.37-0.46-0.49-0.36-0.22-0.38-0.21-0.07
Operating Cash Flow-166-107-76.16-69.14-79.04-45.52-20.77-12.74-4.97-2.84
Capital Expenditures-2.45-0.22-0.06-0.40-0.17-0.03-0.04-0.07-0.03-0.03
Free Cash Flow-168-107-76.22-69.54-79.21-45.55-20.81-12.80-5.00-2.87
Cash & Equivalents16116212713264.7151.3654.191.550.130.42
Total Debt20473.38-----3.592.35-
Net Cash / Debt-42.9588.2312713264.7151.3654.19-2.04-2.220.42
Book Value9.2097.5213012763.0648.3954.70-1.43-1.710.96
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name TherapeuticsMD, Inc.
Country United States
Employees 348
CEO Robert G. Finizio

Stock Information

Ticker Symbol TXMD
Stock Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Unique Identifier NASDAQ: TXMD


TherapeuticsMD, Inc. operates as a women's healthcare company in the United States. The company offers IMVEXXY for the treatment of moderate-to-severe dyspareunia; BIJUVA, a bio-identical hormone therapy combination of 17ß-estradiol and progesterone for the treatment of moderate-to-severe vasomotor symptoms; and ANNOVERA, a ring-shaped contraceptive vaginal system. Its preclinical projects include the development of TX-005HR, a progesterone-alone transdermal cream; TX-006HR, an estradiol and progesterone transdermal cream; and TX-00THR and TX-0008HR, which are transdermal patch product candidates. The company's clinical development product is TX-009HR, an oral progesterone and estradiol formulation. It also manufactures and distributes branded and generic prescription prenatal vitamins under the vitaTrue, vitaPearl, vitaMedMD, and BocaGreenMD Prena1 brands. The company sells its prescription prenatal vitamin and hormone therapy drug products to wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. is headquartered in Boca Raton, Florida.